Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
VVY.AS Stock Summary
Top 10 Correlated ETFs
VVY.AS
In the News
VVY.AS Financial details
Company Rating
Neutral
Market Cap
14.11M
Income
-39.86M
Revenue
10.76M
Book val./share
1.6
Cash/share
1.49
Dividend
-
Dividend %
-
Employees
15
Optionable
No
Shortable
Yes
Earnings
17 Apr 2024
P/E
0
Forward P/E
-0.89
PEG
-
P/S
-
P/B
-
P/C
0.36
P/FCF
-9.44
Quick Ratio
8.14
Current Ratio
9.4
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
-1.74
EPS next Y
-0.61
EPS next Q
-
EPS this Y
103.17%
EPS next Y
-64.92%
EPS next 5Y
-626.71%
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-39.71%
-
-
-
-
SMA20
-88.89%
SMA50
-87.5%
SMA100
-87.5%
Inst Own
-
Inst Trans
-
ROA
-90%
ROE
-131%
ROC
-1.04%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
25.89M
Shs Float
19.19M
-
-
-
-
Target Price
-
52W Range
0.49-19.56
52W High
-
52W Low
-
RSI
11
Rel Volume
0.28
Avg Volume
574.01K
Volume
157.96K
Perf Week
0.75%
Perf Month
-94.42%
Perf Quarter
-94.96%
Perf Half Y
-95.29%
-
-
-
-
Beta
1.616
-
-
Volatility
0.01%, 4.02%
Prev Close
2.08%
Price
0.54
Change
-1.1%
VVY.AS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0.54 | 0 | |
Net income per share | -0.94 | -0.62 | -0.83 | -0.63 | -1.28 | |
Operating cash flow per share | -0.85 | -0.92 | -0.7 | -0.56 | -0.99 | |
Free cash flow per share | -0.85 | -0.93 | -0.73 | -0.56 | -0.99 | |
Cash per share | 0.46 | 3.31 | 1.32 | 0.73 | 1.21 | |
Book value per share | 0.15 | 3.4 | 1.31 | 0.83 | 1.2 | |
Tangible book value per share | 0.15 | 3.4 | 1.28 | 0.8 | 1.18 | |
Share holders equity per share | 0.15 | 3.4 | 1.31 | 0.83 | 1.2 | |
Interest debt per share | -10.11 | 0.04 | 0.02 | 0.01 | 0.01 | |
Market cap | 20.6K | 68.27M | 179.98M | 380M | 227.24M | |
Enterprise value | 16.82K | 27.15M | 153.99M | 365.56M | 200.82M | |
P/E ratio | -2.66 | -8.73 | -10.9 | -30.03 | -8.07 | |
Price to sales ratio | 0 | 0 | 0 | 35.3 | 0 | |
POCF ratio | -2.95 | -5.88 | -12.84 | -33.76 | -10.43 | |
PFCF ratio | -2.94 | -5.86 | -12.28 | -33.67 | -10.42 | |
P/B Ratio | 16.75 | 1.6 | 6.86 | 22.95 | 8.57 | |
PTB ratio | 16.75 | 1.6 | 6.86 | 22.95 | 8.57 | |
EV to sales | 0 | 0 | 0 | 33.96 | 0 | |
Enterprise value over EBITDA | -2.19 | -3.53 | -9.7 | -28.92 | -6.93 | |
EV to operating cash flow | -2.4 | -2.34 | -10.99 | -32.47 | -9.21 | |
EV to free cash flow | -2.4 | -2.33 | -10.51 | -32.39 | -9.21 | |
Earnings yield | -0.38 | -0.11 | -0.09 | -0.03 | -0.12 | |
Free cash flow yield | -0.34 | -0.17 | -0.08 | -0.03 | -0.1 | |
Debt to equity | -67.48 | 0.01 | 0.01 | 0.01 | 0 | |
Debt to assets | -20.5 | 0.01 | 0.01 | 0.01 | 0 | |
Net debt to EBITDA | 0.49 | 5.35 | 1.64 | 1.14 | 0.91 | |
Current ratio | 4.13 | 48.79 | 21.73 | 4 | 9.4 | |
Interest coverage | 0 | -71.98 | -696.39 | -533.58 | -1.21K | |
Income quality | 0.9 | 1.48 | 0.85 | 0.89 | 0.77 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 1.62 | 0 | |
Intangibles to total assets | 0 | 0 | 0.02 | 0.02 | 0.02 | |
Capex to operating cash flow | 0 | 0 | 0.05 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -0.7 | -0.53 | -4.38 | -0.17 | -0.08 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.78 | 6.91 | 4.94 | 3.43 | 5.88 | |
ROIC | 0.09 | -0.18 | -0.6 | -0.78 | -1.08 | |
Return on tangible assets | -1.91 | -0.17 | -0.57 | -0.53 | -0.91 | |
Graham Net | 2.89 | 3.09 | 1.15 | 0.46 | 1.12 | |
Working capital | 3.02K | 44.45M | 27.47M | 15.18M | 27.43M | |
Tangible asset value | 1.22K | 42.65M | 25.66M | 16.02M | 26.01M | |
Net current asset value | 1.16K | 42.18M | 25.26M | 12.27M | 25.82M | |
Invested capital | -67.48 | 0.01 | 0.01 | 0.01 | 0 | |
Average receivables | 68.5K | 346.5K | 365.5K | 1.74M | 3.66M | |
Average payables | 558 | 655.5 | 725 | 2.64K | 3.45K | |
Average inventory | -68.5K | -45.5K | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 113.94 | 0 | |
Days payables outstanding | 12.25 | 2.24 | 2.28 | 0.92 | 5.77 | |
Days of inventory on hand | -1.44K | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 3.2 | 0 | |
Payables turnover | 29.79 | 163.27 | 160.26 | 397.71 | 63.31 | |
Inventory turnover | -0.25 | 0 | 0 | 0 | 0 | |
ROE | -6.29 | -0.18 | -0.63 | -0.76 | -1.06 | |
Capex per share | 0 | 0 | -0.03 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0.54 | 0 | 0 | 0 | |
Net income per share | -0.58 | -0.05 | -0.6 | -0.68 | -0.41 | |
Operating cash flow per share | -0.33 | -0.24 | -0.49 | -0.51 | -0.78 | |
Free cash flow per share | -0.33 | -0.24 | -0.49 | -0.51 | -0.78 | |
Cash per share | 1.03 | 0.73 | 1.16 | 1.16 | 1.49 | |
Book value per share | 0.77 | 0.83 | 1.2 | 1.16 | 1.6 | |
Tangible book value per share | 0.75 | 0.8 | 1.17 | 1.14 | 1.58 | |
Share holders equity per share | 0.77 | 0.83 | 1.2 | 1.16 | 1.6 | |
Interest debt per share | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Market cap | 359.56M | 380.96M | 165.04M | 236.02M | 320.37M | |
Enterprise value | 340M | 366.52M | 140.83M | 209.6M | 290.87M | |
P/E ratio | -7.7 | -96.79 | -3.28 | -3.79 | -7.47 | |
Price to sales ratio | 0 | 35.39 | 0 | 0 | 0 | |
POCF ratio | -54.98 | -80.76 | -16.12 | -20.42 | -15.79 | |
PFCF ratio | -54.78 | -80.83 | -16.12 | -20.41 | -15.79 | |
P/B Ratio | 23.24 | 23.01 | 6.54 | 8.9 | 7.71 | |
PTB ratio | 23.24 | 23.01 | 6.54 | 8.9 | 7.71 | |
EV to sales | 0 | 34.05 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -29.03 | -393.69 | -10.59 | -13.37 | -27.41 | |
EV to operating cash flow | -51.99 | -77.7 | -13.76 | -18.14 | -14.34 | |
EV to free cash flow | -51.8 | -77.77 | -13.75 | -18.12 | -14.33 | |
Earnings yield | -0.03 | 0 | -0.08 | -0.07 | -0.03 | |
Free cash flow yield | -0.02 | -0.01 | -0.06 | -0.05 | -0.06 | |
Debt to equity | 0.02 | 0.01 | 0.01 | 0 | 0 | |
Debt to assets | 0.01 | 0.01 | 0.01 | 0 | 0 | |
Net debt to EBITDA | 1.67 | 15.51 | 1.82 | 1.69 | 2.78 | |
Current ratio | 4.2 | 4 | 7.07 | 9.4 | 19.45 | |
Interest coverage | -1.47K | -63.31 | -1.22K | -1.21K | -411.23 | |
Income quality | 0.56 | 4.79 | 0.81 | 0.74 | 1.89 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0.74 | 0 | 0 | 0 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -0.29 | 0.05 | -0.02 | -0.11 | -0.11 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 3.19 | 0.95 | 4.02 | 4.21 | 3.85 | |
ROIC | -0.74 | -0.11 | -0.53 | -0.58 | -0.26 | |
Return on tangible assets | -0.52 | -0.04 | -0.4 | -0.5 | -0.24 | |
Graham Net | 0.69 | 0.46 | 1 | 1.08 | 1.45 | |
Working capital | 16.86M | 15.18M | 26.61M | 27.43M | 42.44M | |
Tangible asset value | 14.92M | 16.02M | 24.73M | 26.01M | 41.06M | |
Net current asset value | 14.56M | 12.27M | 24.48M | 25.82M | 40.92M | |
Invested capital | 0.02 | 0.01 | 0.01 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 28.09 | 0 | 0 | 0 | |
Days payables outstanding | 5.41 | 0.24 | 4.09 | 2.86 | 1.47 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 3.2 | 0 | 0 | 0 | |
Payables turnover | 16.64 | 378.67 | 22 | 31.46 | 61.19 | |
Inventory turnover | 83K | 0 | 0 | 0 | 0 | |
ROE | -0.75 | -0.06 | -0.5 | -0.59 | -0.26 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
VVY.AS Frequently Asked Questions
What is Vivoryon Therapeutics N.V. stock symbol ?
Vivoryon Therapeutics N.V. is a DE stock and trading under the symbol VVY.AS
What is Vivoryon Therapeutics N.V. stock quote today ?
Vivoryon Therapeutics N.V. stock price is $0.54 today.
Is Vivoryon Therapeutics N.V. stock public?
Yes, Vivoryon Therapeutics N.V. is a publicly traded company.